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Abstract
 
Regulation by transforming growth factor (TGF)-
 
 
 
 plays an important role in immune ho-
meostasis. TGF-
 
 
 
 inhibits T cell functions by blocking both proliferation and differentiation.
Here we show that TGF-
 
 
 
 blocks Th1 differentiation by inhibiting the expression of T-bet,
the apparent masterregulator of T helper (Th)1 differentiation. Restoration of T-bet expression
 
through retroviral transduction of T-bet into developing Th1 cells abrogated the inhibitory
effect of TGF-
 
 
 
. In addition, we show that, contrary to prior suggestions, downregulation of
 
interleukin 12 receptor 
 
 
 
2 chain is not key to the TGF-
 
 
 
–mediated effect. Furthermore, we
 
show that the direct inhibitory effect of TGF-
 
 
 
 on T cells is responsible, at least in part, for
 
the inability of BALB/c mice to mount a 
 
Leishmania
 
-specific Th1 response and to clear
Leishmanial infection.
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Introduction
 
TGF-
 
 
 
 is a pleitropic cytokine which performs multiple
regulatory functions in the immune system (1). One such
role of TGF-
 
 
 
 in regulating immune homeostasis is the in-
hibition of naive T cell differentiation into effector cells.
Specifically, addition of TGF-
 
 
 
 to T cell cultures blocks T
cell differentiation into either the Th1 or Th2 subset (2).
This inhibition of T cell differentiation is separable from
the antiproliferative action of TGF-
 
 
 
 as it can be mani-
fested in the presence of exogenous IL-2, which overcomes
the antiproliferative action of TGF-
 
 
 
.
Although the phenomenon of TGF-
 
 
 
 blockade of T cell
differentiation has been widely addressed, the mechanisms
through which TGF-
 
 
 
 leads to such inhibition have only
recently begun to be examined. Thus, we and others have
recently demonstrated that TGF-
 
 
 
 achieves the inhibition
of T cell differentiation into Th2 effector cells through the
inhibition of the expression of GATA-3 (3, 4), a transcrip-
tion factor crucial for Th2 development (5, 6). Although a
 
key mechanism of TGF-
 
 
 
 inhibition of Th2 differentia-
tion has been revealed by those studies, the mechanisms
of inhibition of Th1 differentiation remained unclear. In
this paper we focus on the mechanism of TGF-
 
 
 
 in-
duced inhibition of Th1 differentiation. It has been pre-
viously demonstrated that TGF-
 
 
 
 inhibits the expression
of IL-12R
 
 
 
2 in differentiating T cells (7).
 
Materials and Methods
 
Mice.
 
CD4-dnTGF-
 
 
 
RII mice were generated as described
previously (8) and were backcrossed onto BALB/c genetic back-
ground. After the n4 generation, mice homozygous for BALB/c
loci reported to be important for BALB/c susceptibility to 
 
Leish-
mania
 
 and IL-4 bias (9, 10), were selected for further breeding.
Selection was based on D11MIT2, D11MIT2, D7MIT101,
D16MIT34, and D5MIT145 markers. The transgene positive
and negative progeny of these mice was used for the experiments.
C57BL/6 and BALB/c mice were purchased from the National
Cancer Institute.
 
Parasites and Infection Protocol.
 
Mice were infected in the right
hind foot with 2 
 
 
 
 10
 
6
 
 stationary phase 
 
Leishmania major
 
 promas-
tigotes of the WR309 substrain and monitored as described pre-
viously (11).
 
In Vitro Restimulation of Lymph Node Cells for Cytokine Produc-
tion.
 
CD4
 
 
 
 T cells were isolated 8 wk after infection from
pooled popliteal and inguinal lymph nodes by negative selection
using mAbs to CD8, MHC class II, B220 and FcR, followed by
incubation with anti–mouse and anti–rat Ig-coated magnetic beads
(PerSeptive Biosystems). T cell–depleted splenocytes obtained from
uninfected C57BL/6 or BALB/c mice were used as a source of
 
APCs. CD4
 
 
 
 
 
T cells from the various infected animals groups were
 
cultures in 96-well plates at 2 
 
 
 
 10
 
5
 
 cells per well together with
 
2 
 
 
 
 10
 
5
 
 APCs in the presence of various concentrations of parasite
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lysate (prepared by sonication of 
 
L. major
 
 promastigotes). After 4 d
of culture, supernatants were collected for cytokine analysis.
 
Assaying for Cytokines in Culture Supernatants.
 
Supernatants were
assayed for the presence of cytokines using kits purchased from
Endogen for IFN-
 
 
 
, IL-4, and IL-5, and from R&D Systems for
IL-13.
 
Retroviral Constructs and Retroviral Transduction.
 
GFP-RV, IL-
12R
 
 
 
2-RV, and T-bet-RV retroviral vectors were described pre-
viously (12, 13). Phoenix-Eco packaging cell line (gift of G. Nolan,
Stanford University, Stanford, CA) was transfected according to Dr.
Nolan’s protocol. CD4
 
 
 
 T cells from BALB/c were transduced us-
ing the above retroviral constructs as described previously (3).
 
Western Blot Analysis.
 
Total T cell lysates were prepared as
described previously (8), resolved by 10% SDS-PAGE, trans-
ferred to a PVDF membrane (Millipore), probed with anti–T-bet
rabbit antisera (gift of L. Glimcher, Harvard University, Boston,
MA), and developed using the ECL system (Pierce Chemical
Co.). Membranes was subsequently stripped of antibodies with
0.1 M Glycine-HCl for 30 min at room temperature, and re-
probed with anti–
 
 
 
-tubulin specific mAb (Sigma-Aldrich).
 
FACS
 
®
 
 Analyses.
 
Intracellular cytokine staining was per-
formed as described previously (8). 20,000 events were collected,
and after gating on GFP
 
 
 
 or GFP
 
 
 
 cells, intracellular cytokine
staining was analyzed. Gates for cytokine staining were set using
isotype matched control antibody staining. Gates for GFP (FL1)
positive cells were determined using nontransduced controls.
 
RNA Preparation and Semiquantitative RT-PCR.
 
RNA and cDNA
were prepared as described previously (3). Subsequently, each
sample was subjected to PCR with sense and antisense primers
for 
 
 
 
-actin and T-bet. Primers for 
 
 
 
-actin were described pre-
viously (3) and for T-bet are: 5
 
 
 
 TTC CCA TTC CTG TCC
TTC ACC G (sense) and 5
 
 
 
 GGA AGG TCG GGG TAA AAA C
(antisense). To amplify mRNA specifically, and not contaminating
genomic DNA, primers for both 
 
 
 
-actin and T-bet were designed
to span an intron. PCR were performed at different numbers of
cell cycles to ensure that comparison of PCR products for various
samples is performed in the linear part of an amplification curve.
 
Results
 
TGF-
 
 
 
 Blockade of Th1 Differentiation Is Independent of In-
hibition of IL-12 Receptor 
 
 
 
2 Chain.
 
Since IL-12 and IL-
12 induced signal transducer and activator of transcription
 
(STAT)-4 activation has been shown to be crucial for Th1
differentiation (14), it was suggested that TGF-
 
 
 
 inhibits
Th1 differentiation through the inhibition of IL-12 recep-
tor expression. To test this hypothesis we used a retroviral
vector in order to introduce exogenous IL-12R
 
 
 
2 chain
into differentiating Th1 cells and subjected these cells to
TGF-
 
 
 
 treatment. We reasoned that if TGF-
 
 
 
 inhibited
the development of Th1 cells through the inhibition of IL-
12 receptor expression then the cells transduced with the
retrovirus, and hence expressing exogenous IL-12R
 
 
 
2
chain, would be resistant to TGF-
 
 
 
 inhibition. Infection of
T cells with this retroviral vector enabled IL-12 signaling in
Th2 cells (12), which do not normally express this chain of
IL-12 receptor and thus do not respond to IL-12 signaling.
The retroviral construct contains a bicistronic element car-
rying the GFP gene, thereby distinguishing IL-12R
 
 
 
2–
expressing T cells on the basis of green fluorescence. As
control retroviral vector, we used an “empty” vector
containing only the GFP gene. As can be seen from Fig. 1,
in agreement with previously reported data addition of
TGF-
 
 
 
 to the cultures of developing Th1 cells inhibited
the percentage of IFN-
 
 
 
 
 
 cells. Viral transduction of IL-12
receptor 
 
 
 
2 chain did not, however, provide any protec-
tive benefit against inhibitory effects of TGF-
 
 
 
 to the de-
veloping Th1 cells (Fig. 1). TGF-
 
 
 
 inhibited Th1 differen-
tiation in cells expressing retrovirally transduced IL-12R
 
 
 
2
chain to the same degree as in cells transduced with the
control vector (52 
 
 
 
 16% inhibition by TGF-
 
 
 
 for IL-
12R
 
 
 
2-RV transduced cells vs. 56 
 
 
 
 3% in GFP-RV
transduced cells; 
 
n 
 
  
 
3 experiments).
 
TGF-
 
 
 
 Inhibits T-bet Expression during Th1 Develop-
ment.
 
The above results indicate that although TGF-
 
 
 
 in-
hibits IL-12R
 
 
 
2 chain expression, this inhibition is likely
secondary to the inhibitory effect of TGF-
 
 
 
 on Th1 cell
development, since the introduction of exogenous IL-
12R
 
 
 
2 molecule did not restore Th1 differentiation inhib-
ited by TGF-
 
 
 
. Therefore, as a next step we investigated
whether TGF-
 
 
 
 inhibits T-bet, a factor which expression
seems to be limiting for Th1 development (13), and the
one that is preceding IL-12R
 
 
 
2 chain expression (15).
Figure 1. Ectopic expression of IL-12R 2
does not reverse the inhibitory effect of
TGF-  on number of differentiating Th1
cells. Primary CD4  T cells were stimulated,
infected with GFP-RV (top) or IL-12R 2-
RV (bottom), and cultured under Th1 con-
ditions in the presence or absence of
rhuTGF- 1 (3 ng/ml). On day 5 after pri-
mary activation T cells were stimulated with
PMA/ionomycin for 5 h. Cells were ana-
lyzed by flow cytometry for IFN-  ex-
pression in either infected GFP  or unin-
fected GFP   T cells. Results of one
representative experiment out of three ex-
periments done are shown. 
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T-bet expression is also independent of IL-12 and STAT-4
signaling (15).
As can be seen from the results of Western blot analysis
(Fig. 2 A) TGF-
 
 
 
 inhibited T-bet expression in Th1 cul-
tures 20 h after T cell activation. To test whether TGF-
 
 
 
inhibits T-bet expression at the transcriptional or transla-
tional level we investigated T-bet mRNA expression after
TGF-
 
 
 
 treatment by RT-PCR analysis. As can be seen
from Fig. 2 B, activation of T cells under Th1 culture con-
ditions induced expression of T-bet mRNA and TGF-
 
 
 
inhibited T-bet induction under those conditions. Thus,
TGF-
 
 
 
 inhibits expression of a critical Th1 differentiating
factor, at the mRNA and protein levels.
 
Reversal of TGF-
 
 
 
 Inhibition on Th1 Differentiation by Ec-
topic Expression of T-bet in T Cells.
 
To test whether inhi-
bition of T-bet expression by TGF-  constitutes the
mechanism whereby TGF-  inhibits Th1 differentiation
we took advantage of the retroviral system to introduce ex-
ogenous T-bet into differentiating CD4 T cells (13). Intro-
duction of T-bet into differentiating Th1 cells increased
the percentage of IFN-   cells in Th1 differentiation cul-
tures (Fig. 3). In accordance with the previous data, cells
that were transduced with the control vector or cells that
were not transduced with T-bet (GFP  cells from T-bet-
RV group) were inhibited by TGF- . Remarkably, exoge-
nous expression of T-bet rendered differentiating Th1 cells
completely resistant to TGF-  inhibition (Fig. 3). The re-
sults of this experiment demonstrated that inhibition of
T-bet by TGF-  explains the inhibition of Th1 differentia-
tion by TGF- , since the restoration of T-bet expression
alone through retroviral transduction completely reversed
this inhibition (4   7% inhibition by TGF-  for T-bet-
RV transduced cells vs. 56   3% in GFP-RV transduced
cells; n   3 experiments).
Direct Effect of TGF-  on T Cells Is Responsible for the Fail-
ure of BALB/c Mice to Develop a Th1 Response to L. Major.
We considered that the inhibition of Th1 development by
TGF-  might play an important physiological role in many
pathophysiological immune responses. Thus, we investi-
gated the well-known inability of BALB/c mice to mount
a protective Th1 response to the intracellular parasite L.
major (16). Several mechanisms have been proposed to ex-
plain this defect. One popular hypothesis is based on obser-
vations of the decreased expression of IL-12R 2 chain on
T cells from infected BALB/c mice (17, 18) and the ability
of IL-4 to inhibit the expression of the  2 chain of the IL-
12 receptor on T cells of BALB/c origin (19). This hy-
pothesis proposes that defective Th1 response in these mice
results from the decreased expression of IL-12 receptor and
therefore signaling by IL-12. However, recent experiments
demonstrated that BALB/c mice expressing a transgenic
IL-12R 2 chain on T cells were as susceptible to L. major
and equally incapable of mounting a Th1 response to the
parasite as nontransgenic BALB/c mice (20).
These experiments demonstrated that Leishmania did not
inhibit Th1 differentiation through the inhibition of IL-12
signaling in T cells. Since we demonstrated that TGF-  did
not inhibit Th1 differentiation through the inhibition of
IL-12 signaling in T cells we tested whether TGF-  is in-
Figure 2. TGF-  inhibits T-bet expression in activated primary T cells.
(A) CD4  T cells were stimulated with anti-CD3/CD28 mAbs (5  g/ml
each) in the presence or absence of rmIL-4 (1,000 U/ml), IL-12 (3.5 ng/
ml), and/or rhuTGF- 1 (3 ng/ml). After 20 h of culture, total cell lysates
were normalized for protein level and resolved by 10% SDS-PAGE followed
by Western immunoblotting with an anti–T-bet–specific rabbit antiserum.
Results of one representative experiment out of three experiments done
are shown. (B) CD4  T cells were stimulated like in A, after 20 h of cul-
ture, total cell RNA was prepared, reverse transcribed into cDNA, and
amplified using  -actin and T-bet specific primers. Experiment was con-
ducted twice and results of a representative experiment are shown.
Figure 3. Ectopic expression of T-bet
abrogates the inhibitory effect of TGF-  on
number of differentiating Th1 cells. Primary
CD4  T cells were stimulated, infected with
GFP-RV (top) or T-bet-RV (bottom), and
cultured under Th1 conditions in the pres-
ence or absence of rhuTGF- 1 (3 ng/ml).
On day 5 after primary activation, T cells
were stimulated with PMA/ionomycin for
5 h. Results of one representative experiment
out of three experiments done are shown.1502 Inhibition of Th1 Development by TGF- 
volved in the inhibition of the anti-Leishmanial Th1 re-
sponse. It has been shown previously that infection with
Leishmania leads to increased TGF-  production, and that
TGF-  contributes to the direct inhibition of macrophage
anti-Leishmanial function (21, 22). To test our hypothesis
that L. major inhibits the generation of the protective anti-
Leishmania Th1 response through TGF- –mediated direct
inhibition of Th1 differentiation, we challenged BALB/c
mice expressing a transgenic dominant-negative TGF-  re-
ceptor type II in T cells with L. major.
We have previously described the generation of trans-
genic mice expressing dominant negative TGF-  receptor
II (CD4-dnTGF RII) exclusively on T cells by way of a T
cell–specific promoter (8). In these mice TGF-  signaling
is blocked in T cells, but not other cells. For the L. major
study, we backcrossed these mice (originally maintained on
the C57BL/6 background) to BALB/c mice. At the n4
generation we selected and used for experiments mice ho-
mozygous for the BALB/c alleles at the loci demonstrated
to be important for Leishmania susceptibility as well as for
IL-4 skewing (9, 10) (data not shown).
Footpad infection of BALB/c mice and CD4-dnTGF-
 RII transgene negative littermates resulted in progressive
proliferation of the parasites leading to footpad swelling
(Fig. 4), and eventually to large nonhealing lesions. Strik-
ingly, CD4-dnTGF- RII transgene positive BALB/c mice
arrested Leishmania infection as effectively as genetically re-
sistant C57BL/6 mice. Thus, susceptibility to Leishmania
infection requires TGF-  signaling in T cells.
Since TGF-  inhibits Th1 differentiation and the sus-
ceptibility to Leishmania infection is associated with the lack
of Th1 response we tested the ability of T cells from
CD4 dnTGF- RII BALB/c mice to mount a Leishmania-
specific Th1 response. As shown in Fig. 5, infection of
transgene positive BALB/c mice resulted in a potent Leish-
mania antigen-specific Th1 response. In fact, the levels of
IFN-  produced by CD4  T cells from CD4 dnTGF-
 RII Tg  mice in response to total Leishmania antigen
were even higher than the levels made by the genetically
resistant C57BL/6 strain. Transgene negative littermates
displayed the strong Th2 response and lack of IFN-  secre-
tion typical to the BALB/c strain. Strikingly, Tg  BALB/c
mice also exhibited a marked Th2 response despite the de-
velopment of a very strong Th1 response.
Discussion
Our results uncover an important molecular mechanism
by which TGF-  mediates the inhibition of T cell differ-
entiation into type 1 Th cells. First, we demonstrate that
inhibition of T-bet, a recently discovered molecular
switch which determines Th1 differentiation (13), is criti-
cal for TGF- –induced inhibition of Th1 differentiation.
Second, we show here that downregulation of IL-12 re-
ceptor  2 chain expression appears not to be important for
the TGF- –mediated affect. Interestingly, it has been
shown recently that induction of T-bet in Th1 cells does
not require IL-12 signaling, but rather that T-bet expres-
sion is required for IL-12R 2 expression (15). Since it was
also shown that T-bet can directly transactivate IFN- 
gene expression without the need for IL-12 signaling, it is
likely that the observed inhibition of IL-12R 2 chain by
TGF-  is an event secondary to T-bet inhibition. In the
same way that IL-12R 2 alone cannot restore Th1 inhibi-
tion by TGF- , restoration of IL-12 signaling through ex-
pression of IL-12R 2 also did not reestablish Th1 differ-
entiation inhibited by IL-4 (12, 23). Together, these data
support the notion that IL-12 plays a limited role in the
direct activation of Th1 differentiation. As suggested by
Mullen et al. (15), the role of IL-12 is likely limited more
to a supporting role as a growth factor for Th1 cells rather
than a differentiation factor. The ability of retrovirally in-
troduced T-bet to overcome TGF- –induced inhibition
of Th1 differentiation demonstrates that T-bet is the most
critical and primary target for the inhibition of Th1 differ-
entiation by TGF- .
In addition to uncovering the mechanism through
which TGF-  inhibits Th1 differentiation in vitro, we de-
scribe an important role for TGF-  in the inhibition of
Th1 differentiation in vivo. Specifically, we show here
that TGF-  signaling in T cells plays a critical role in the
inhibition of Th1 responses to Leishmania and that TGF- 
is at least partially responsible for the susceptibility to L.
major of BALB/c mice. The susceptibility of BALB/c mice
to Leishmania and the lack of a Leishmania-specific Th1 re-
sponse has been previously linked to an early burst of IL-4
production by V 4V 8 CD4  T cells in the first 48 h af-
ter infection (24). Thus, early (but not late) depletion of
IL-4 or the V 4V 8 subset resulted in protective Th1 re-
Figure 4. CD4-dnTGF- RII BALB/c mice are resistant to L. major
infection. Mice were infected in the right foot with 2   106 stationary
phase L. major promastigotes. The mean footpad thickness of infected and
uninfected feet was determined for each group of mice, and the ratio of
these means calculated and plotted. The plot shows data from four com-
bined experiments, with total of 10 mice for each group.1503 Gorelik et al. Brief Definitive Report
sponses in BALB/c mice (25). Nevertheless, administra-
tion of IL-4 to the resistant mouse strain, C57BL/6, did
not divert the Th1 response to Th2 and render these ani-
mals susceptible to parasite growth (26). These results sug-
gest that IL-4 is necessary, but not sufficient for the in-
hibition of the Leishmania-specific Th1 response and
susceptibility to infection. Importantly, even when block-
ing of IL-4 rendered BALB/c mice resistant to Leishmania
it did not fully restore Th1 response in these mice (26, 27).
Together these data indicate that IL-4 production in
BALB/c mice is not the single factor which inhibits the
Th1 response and causes susceptibility to infection. There-
fore, our observation that abrogation of TGF-  signaling
in T cells renders BALB/c mice resistant to Leishmania in-
fection and permits the generation of the Leishmania-spe-
cific Th1 response provides an important piece of infor-
mation to this puzzle.
TGF-  has been previously demonstrated to play an
important role in the progression of Leishmaniasis. Spe-
cifically, it was shown that Leishmania infection leads to
TGF-  production (22). Importantly, administration of
TGF-  exacerbated disease in C57BL/6 mice, while ad-
ministration of anti–TGF-  antibodies ameliorated the
disease in BALB/c mice (22). Since TGF-  can directly
inhibit the anti-Leishmanial properties of macrophages
(21, 28), it was suggested that TGF-  plays an important
role in the progression of the disease through the direct
inhibition of macrophage function. Since we specifically
blocked TGF-  signaling in T cells in the current study
as opposed to a general blockade achieved with antibod-
ies in the former study (22), we conclude that TGF- 
plays a critical role in susceptibility to Leishmania by di-
rectly inhibiting T cell function. Specifically, we demon-
strate that T cell–specific abrogation of TGF-  signaling
renders BALB/c mice resistant to Leishmania infection
and permits the generation of parasite-specific Th1 cells.
Th1 differentiation and resistance to Leishmania did not
result from low IL-4 production and Th2 differentiation
in the absence of TGF-  signaling in T cells. In fact,
CD4-dnTGF- RII BALB/c mice displayed increased
Th2 cytokine production.
Early IL-4 production and V 4V 8 CD4  cells appear
to be necessary to downregulate IL-12 receptor  2 chain
expression, observations which led to the proposal that in-
hibiting this receptor blocked the IL-12 signal in T cells
and consequently prevented Th1 differentiation. None-
theless, IL-12R 2 downregulation as a result of Leishmania
infection is not responsible for the lack of Th1 differentia-
Figure 5. L. major–infected CD4-dnTGF- RII BALB/c
mice produce Th1-type cytokines. CD4  T cells isolated
from lymph nodes of mice infected with L. major promas-
tigotes 8 wk earlier and were set up in the presence of
different concentrations of L. major lysate and 4 d later cul-
ture supernatant was collected for cytokine analysis.1504 Inhibition of Th1 Development by TGF- 
tion as BALB/c mice expressing a transgenic IL-12R 2 on
T cells failed to mount Th1 response and lead to Leishma-
nia resistance (20). Since downregulation of IL-12R 2 ex-
pression was neither required to inhibit Th1 differentiation
by IL-4 (12, 23) nor by TGF-  it appears that downregu-
lation of T-bet by TGF-  could be a mechanism for in
vivo susceptibility of BALB/c mice to Leishmania. It is in-
teresting in this regard that T-bet maps to Chromosome
11 (29), a chromosome that contains a Leishmania suscepti-
bility gene (9).
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